abstract |
The present invention relates to novel chemical compounds, application of such compounds as anticoagulants, and plasma-replacement solutions based thereon, for treating thromboembolic complications of diseases such as myocardial infarction, stroke and thrombosis of the deep vein or pulmonary artery; It can be used to prevent coagulation as a result of injury, surgery, sepsis, various obstetric pathologies, disasters, medicine, resuscitation, and the like. |